FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for ZOLADEX (goserelin) from TerSera Therapeutics LLC. The approval includes changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• Zoladex (goserelin)

Snippet

SUPPL AP for ZOLADEX (GOSERELIN)